BBVSX
Price
$14.71
Change
+$0.17 (+1.17%)
Updated
Jul 17 closing price
Net Assets
8.24B
VMVIX
Price
$65.67
Change
+$0.51 (+0.78%)
Updated
Jul 17 closing price
Net Assets
30.57B
Interact to see
Advertisement

BBVSX vs VMVIX

Header iconBBVSX vs VMVIX Comparison
Open Charts BBVSX vs VMVIXBanner chart's image
Bridge Builder Small/Mid Cap Value
Price$14.71
Change+$0.17 (+1.17%)
VolumeN/A
Net Assets8.24B
Vanguard Mid-Cap Value Index Investor
Price$65.67
Change+$0.51 (+0.78%)
VolumeN/A
Net Assets30.57B
BBVSX vs VMVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BBVSX vs. VMVIX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBVSX is a Hold and VMVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 30.6B vs. BBVSX (8.24B). VMVIX pays higher dividends than BBVSX: VMVIX (2.14) vs BBVSX (1.25). BBVSX was incepted earlier than VMVIX: BBVSX (10 years) vs VMVIX (19 years). BBVSX (0.68) is less costly to investors than VMVIX (0.19). BBVSX is a more actively managed with annual turnover of: 46.00 vs. VMVIX (19.00). BBVSX has a lower initial minimum investment than VMVIX: BBVSX (0) vs VMVIX (3000). VMVIX annual gain was more profitable for investors over the last year : 4.95 vs. BBVSX (-1.09). VMVIX return over 5 years is better than : 67.64 vs. BBVSX (54.14).
BBVSXVMVIXBBVSX / VMVIX
Total Expense Ratio0.410.19216%
Annual Report Gross Expense Ratio0.680.19358%
Fund Existence10 years19 years-
Gain YTD3.5922.380151%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.24B30.6B27%
Annual Yield % from dividends1.252.1458%
Returns for 1 year-1.094.95-22%
Returns for 3 years21.6927.9378%
Returns for 5 years54.1467.6480%
Returns for 10 years63.5685.7274%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PVLA31.232.81
+9.89%
Palvella Therapeutics Inc
TDACU10.43N/A
N/A
Translational Development Acquisition Corp
ALSN88.92-0.13
-0.15%
Allison Transmission Holdings
EXPI10.19-0.12
-1.16%
eXp World Holdings
NVNI0.34-0.01
-4.12%
Nvni Group Limited